Streetbeat News

Analyst Ratings

DVN

Recent options trading activity on Devon Energy (NYSE:DVN) shows a mix of bullish and bearish sentiment among large investors. The trading suggests a price range of $35 to $55 for DVN in the short term. Analysts have mixed ratings, with a consensus target price of $53.8.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:16 pm

RNA

Goldman Sachs has initiated coverage on Avidity Biosciences (NASDAQ:RNA) with a Buy rating and a $59 price target, citing the company's promising RNA therapeutics platform for rare diseases. Avidity's lead asset, del-desiran, is in Phase 3 trials for myotonic dystrophy, with potential blockbuster sales. The company also has promising candidates for other muscular dystrophies.

Portfolio Pulse from Vandana Singh

September 24, 2024 | 6:15 pm

TXRH

Wedbush analyst Nick Setyan has reiterated an Outperform rating for Texas Roadhouse (NASDAQ:TXRH) and maintained a price target of $190.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 6:05 pm

GNRC

Piper Sandler analyst Kashy Harrison has reiterated an Overweight rating on Generac Holdings (NYSE:GNRC) with a maintained price target of $175.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 6:02 pm

V

Monness, Crespi, Hardt analyst Gus Gala has reiterated a Neutral rating on Visa (NYSE:V).

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 6:02 pm

PPBI

Analysts have mixed views on Pacific Premier Bancorp (NASDAQ:PPBI) with recent ratings showing a shift towards a more neutral stance. The average 12-month price target has increased to $26.5, indicating a slight positive outlook. Despite revenue challenges, the company maintains strong profitability and financial health.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:01 pm

UNH

UnitedHealth Group (UNH) has seen a surge in options activity, with a significant bearish sentiment among investors. The options activity includes 17 puts and 7 calls, indicating a potential price movement between $300 and $660. The stock is currently trading at $572.63, with a slight decrease of 0.14%. Analysts have set an average target price of $591, and Cantor Fitzgerald has downgraded its rating to Overweight.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:01 pm

BRZE

Braze (NASDAQ:BRZE) has received mixed analyst ratings over the past three months, with a majority being bullish. The average 12-month price target is $61.15, a decrease from the previous $63.62. Analysts have adjusted their ratings and price targets based on market conditions and company performance. Braze's financial performance shows strong revenue growth but challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:01 pm

CBUS

Analysts have varied opinions on Cibus (NASDAQ:CBUS), with recent ratings showing a mix of bullish sentiments. The average 12-month price target is $22.3, slightly down from $22.67. Cibus has shown strong revenue growth but struggles with profitability. Analysts have adjusted their price targets, reflecting evolving market conditions.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:00 pm

APO

Investors are showing a bearish stance on Apollo Global Management (NYSE:APO) with significant options trading activity. The sentiment is split with 44% bullish and 55% bearish. The trading activity suggests a price range of $77.5 to $140.0 for APO. Analysts have adjusted their ratings and price targets, reflecting mixed expectations.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 6:00 pm